A Smart Intracellular Self‐Assembling Bioorthogonal Raman Active Nanoprobe for Targeted Tumor Imaging (Adv. Sci. 34/2023)

Targeted Tumor Imaging A Raman-active bioorthogonal enzyme recognition nanoprobe (nanoSABER) has been developed for selective imaging of aggressive prostate tumors. The nanoSABER selectively self-assembled inside targeted tumors and facilitated imaging with high optical contrast and sensitivity, indicating its potential for Raman-based aggressive cancer imaging. More details can be found in article number 2304164 by Jeff W. M. Bulte, Ishan Barman, and co-workers.